Logo image of ORV.CA

ORVANA MINERALS CORP (ORV.CA) Stock Fundamental Analysis

Canada - TSX:ORV - CA68759M1014 - Common Stock

1.48 CAD
+0.09 (+6.47%)
Last: 10/15/2025, 7:00:00 PM
Fundamental Rating

2

ORV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 810 industry peers in the Metals & Mining industry. There are concerns on the financial health of ORV while its profitability can be described as average. ORV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

ORV had negative earnings in the past year.
ORV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ORV reported negative net income in multiple years.
In the past 5 years ORV always reported a positive cash flow from operatings.
ORV.CA Yearly Net Income VS EBIT VS OCF VS FCFORV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.02%, ORV is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of -5.08%, ORV is in the better half of the industry, outperforming 72.96% of the companies in the same industry.
With an excellent Return On Invested Capital value of 14.32%, ORV belongs to the best of the industry, outperforming 97.41% of the companies in the same industry.
Industry RankSector Rank
ROA -2.02%
ROE -5.08%
ROIC 14.32%
ROA(3y)-4.01%
ROA(5y)-2.49%
ROE(3y)-9.9%
ROE(5y)-6.13%
ROIC(3y)N/A
ROIC(5y)N/A
ORV.CA Yearly ROA, ROE, ROICORV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Operating Margin, with a value of 19.87%, ORV belongs to the top of the industry, outperforming 92.47% of the companies in the same industry.
ORV's Operating Margin has improved in the last couple of years.
ORV has a better Gross Margin (28.09%) than 90.37% of its industry peers.
In the last couple of years the Gross Margin of ORV has declined.
Industry RankSector Rank
OM 19.87%
PM (TTM) N/A
GM 28.09%
OM growth 3Y16%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A
ORV.CA Yearly Profit, Operating, Gross MarginsORV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ORV is still creating some value.
ORV has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ORV has about the same amount of shares outstanding.
The debt/assets ratio for ORV is higher compared to a year ago.
ORV.CA Yearly Shares OutstandingORV.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ORV.CA Yearly Total Debt VS Total AssetsORV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ORV has an Altman-Z score of 1.57. This is a bad value and indicates that ORV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ORV (1.57) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.43 indicates that ORV is not too dependend on debt financing.
ORV's Debt to Equity ratio of 0.43 is on the low side compared to the rest of the industry. ORV is outperformed by 71.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 1.57
ROIC/WACC1.64
WACC8.71%
ORV.CA Yearly LT Debt VS Equity VS FCFORV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

ORV has a Current Ratio of 1.14. This is a normal value and indicates that ORV is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.14, ORV perfoms like the industry average, outperforming 42.10% of the companies in the same industry.
A Quick Ratio of 0.75 indicates that ORV may have some problems paying its short term obligations.
ORV has a Quick ratio of 0.75. This is in the lower half of the industry: ORV underperforms 62.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.75
ORV.CA Yearly Current Assets VS Current LiabilitesORV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ORV have decreased strongly by -783.87% in the last year.
Looking at the last year, ORV shows a quite strong growth in Revenue. The Revenue has grown by 14.19% in the last year.
ORV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.92% yearly.
EPS 1Y (TTM)-783.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.67%
Revenue 1Y (TTM)14.19%
Revenue growth 3Y-5.05%
Revenue growth 5Y-7.92%
Sales Q2Q%6.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ORV.CA Yearly Revenue VS EstimatesORV.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ORV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ORV.CA Price Earnings VS Forward Price EarningsORV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ORV is valued cheaper than 97.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.84
ORV.CA Per share dataORV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ORV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORVANA MINERALS CORP

TSX:ORV (10/15/2025, 7:00:00 PM)

1.48

+0.09 (+6.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-19 2025-11-19
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap202.20M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.38
P/FCF N/A
P/OCF 6.27
P/B 2.53
P/tB 2.53
EV/EBITDA 4.84
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.24
OCFY15.94%
SpS1.07
BVpS0.59
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.02%
ROE -5.08%
ROCE 19.89%
ROIC 14.32%
ROICexc 18.45%
ROICexgc 18.45%
OM 19.87%
PM (TTM) N/A
GM 28.09%
FCFM N/A
ROA(3y)-4.01%
ROA(5y)-2.49%
ROE(3y)-9.9%
ROE(5y)-6.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y17.47%
ROICexcg growth 5YN/A
ROICexc growth 3Y17.47%
ROICexc growth 5YN/A
OM growth 3Y16%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA 0.78
Cap/Depr 251.49%
Cap/Sales 25.41%
Interest Coverage 250
Cash Conversion 73.32%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.75
Altman-Z 1.57
F-Score4
WACC8.71%
ROIC/WACC1.64
Cap/Depr(3y)94.02%
Cap/Depr(5y)82.27%
Cap/Sales(3y)14.91%
Cap/Sales(5y)13.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-783.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.19%
Revenue growth 3Y-5.05%
Revenue growth 5Y-7.92%
Sales Q2Q%6.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y392.51%
EBIT growth 3Y10.14%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-149.45%
FCF growth 3Y34.5%
FCF growth 5Y10.5%
OCF growth 1Y10.13%
OCF growth 3Y-0.18%
OCF growth 5Y2.68%